Position in TARA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,654,263
-$3,149,064 QoQ
Shares Held
2,265,514
0.0% QoQ
Ownership
3.83%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#6
of 120 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in TARA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Blackstone Inc. holds $252,665,757 across 52 Biotechnology names. TARA ranks #12 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AUTL |
Autolus Therapeutics plc
|
20,485,611 | $32,776,977 | |
| 2 | DFTX |
Definium Therapeutics, Inc.
|
561,612 | $26,418,228 | |
| 3 | DMRA |
Damora Therapeutics, Inc.
|
1,002,971 | $26,087,275 | |
| 4 | ARTV |
Artiva Biotherapeutics, Inc.
|
2,403,437 | $23,313,338 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
237,108 | $22,565,568 | |
| 6 | ALXO |
Alx Oncology Holdings Inc
|
6,593,543 | $13,648,634 | |
| 7 | XFOR |
X4 Pharmaceuticals, Inc
|
2,681,922 | $12,524,575 | |
| 8 | IKT |
Inhibikase Therapeutics, Inc.
|
5,938,276 | $12,054,700 |
All Filings in TARA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,654,263 | 2,265,514 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $11,803,327 | 2,265,514 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $10,178,498 | 1,909,662 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $8,307,029 | 1,909,662 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $5,786,275 | 1,909,662 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $7,429,618 | 1,744,042 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $8,870,400 | 1,680,000 | Shares | Other | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||